Links
Cancer risk casts doubt over future of HRT
The time has come to "seriously question" whether hormone-replacement therapy has any role in modern medicine, an expert says today in the medical journal the Lancet.
He argues that new research linking a form of HRT to higher mortality rates in lung cancer is the latest in a long line of evidence highlighting the serious risks of the therapy.
The article, by the medical academic Apar Kishor Ganti, published with the research, claims the results could be "another nail in the coffin for hormone-replacement therapy", used by women to ease the symptoms of menopause. Previous studies have shown that HRT, which is said to make women feel and look younger, can also increase the risk of breast cancer, heart disease and strokes.